HF
GRNAW

HRT Financial’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

HRT Financial’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30,224
Closed -$23K – 3988
2022
Q1 		$23K Buy
+30,224
New +$22.1K ﹤0.01% 2817

Other funds holding GRNAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
AC
Ayrton Capital Westport, Connecticut $14.7M AUM 12.82% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

HRT Financial's GRNAW Position: Q2 2022 in Review

HRT Financial sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q2 2022, closing a stake of 30,224 shares — an estimated $23K sold.

HRT Financial first reported a position in GRNAW in Q1 2022 and held it in 1 quarter. The position peaked at $23K in Q1 2022. 21 funds tracked by Wall St. Rank hold GRNAW as of Q2 2022.

  • HRT Financial reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q2 2022 after selling out during the quarter.
  • HRT Financial sold 30,224 GreenLight Biosciences Holdings, PBC Warrant shares in Q2 2022, an estimated $23K.
  • HRT Financial first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2022 and held it in 1 quarter.
  • HRT Financial's GreenLight Biosciences Holdings, PBC Warrant position peaked at $23K in Q1 2022.
  • 21 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.